腹腔镜远端胃切除术与全胃切除术治疗中三分之一进展期胃癌的对比研究
该回顾性研究纳入2005年4月至2014年6月间379例行腹腔镜远端胃切除术(LADG)或全胃切除术(LATG)联合D2淋巴结清扫的中三分之一进展期胃癌患者,经倾向性评分匹配后比较短期与长期结局。结果显示LADG组手术时间更短、出血量更少、术后排气和住院时间更短、总费用更低,两组并发症率无显著差异,5年总生存率分别为64.4%和61.0%(P=0.548),切除范围并非独立预后因素。结论认为在保证近端切缘阴性的前提下,LADG是可行的优选术式。
要点
- LADG组手术时间、出血量、排气时间、住院时间及费用均优于LATG组
- 两组术后并发症率无显著差异
- 5年总生存率LADG组64.4% vs LATG组61.0%(P=0.548)
核心结论
- 对于中三分之一进展期胃癌,LADG联合D2淋巴结清扫短期结局优于LATG且长期生存相似,推荐在近端切缘阴性前提下作为优选术式。
研究设计与样本
- 回顾性分析2005年4月至2014年6月间379例行LADG或LATG联合D2淋巴结清扫的中三分之一进展期胃癌患者,采用倾向性评分匹配比较两组短期和长期结局。
主要发现
- LADG组手术时间显著短于LATG组(212.74 vs. 241.79 min,P < 0.001)。
- LADG组估计出血量显著少于LATG组(114.38 vs. 181.51 ml,P = 0.000)。
- LADG组首次排气时间和术后住院时间均短于LATG组。
- LATG组总住院费用显著高于LADG组(71187.58 vs. 65783.25 RMB,P = 0.000)。
- 两组术后并发症率无显著差异;5年总生存率LADG组64.4%、LATG组61.0%(P = 0.548),切除范围不是总生存的独立预后因素。
临床怎么用
- 在中三分之一进展期胃癌中,若近端切缘可保证阴性,可优先选择LADG联合D2淋巴结清扫以改善短期结局并降低费用。
局限性
- 本研究为回顾性分析,结论需前瞻性研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There still remains controversy for the choice of resection extent for gastric cancer involving the middle-third of the stomach. The aim of this study was to compare the technical feasibility and long-term outcomes of laparoscopy-assisted distal gastrectomy (LADG) versus laparoscopy-assisted total gastrectomy (LATG) for middle-third advanced gastric cancer (AGC) and to determine which is the optimal surgical procedure. METHODS: For this study, clinical data for 379 patients who underwent LADG or LATG with D2 lymph node dissection between April 2005 and June 2014 were analyzed retrospectively. The short- and long-term outcomes were compared between the propensity score-matched groups. RESULTS: The LADG group had a significantly shorter operating time (212.74 vs. 241.79 min, P < 0.001), less estimated blood loss (114.38 vs. 181.51 ml, P = 0.000), shorter first flatus and postoperative hospital stay. Additionally, the total cost of hospitalization was significantly higher in the LATG group than LADG group (71187.58 vs. 65783.25 RMB, P = 0.000). There were no significant differences in postoperative complications rate between the LADG group and the LATG group. The 5-year overall survival (OS) rates were 64.4% in the LADG group and 61.0% in the LATG group (P = 0.548). The resection extent was not an independent prognostic factor for the OS. CONCLUSIONS: LADG with D2 nodal dissection is a feasible treatment strategy for middle-third AGC with better short-term outcomes and similar long-term survival rates compared with LATG. We recommended that DG should be the optimal surgical procedure for middle one-third AGC under the premise of negative proximal resection margin.
引用
- Li Z, Ji G, Bai B, et al. Laparoscopy-assisted distal gastrectomy versus laparoscopy-assisted total gastrectomy with D2 lymph node dissection for middle-third advanced gastric cancer. Surg Endosc. 2017. PMID: 29098430. doi:10.1007/s00464-017-5919-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。